AYTU vs. LYSDY
AYTU (Aytu BioPharma, Inc.) and LYSDY (Lynas Rare Earths Ltd ADR) are both stocks. AYTU operates in Drug Manufacturers - Specialty & Generic (Healthcare), while LYSDY operates in Other Industrial Metals & Mining (Basic Materials). Over the past 5 years, AYTU returned -54.03%/yr vs 25.47%/yr for LYSDY. At a 0.08 correlation, their price movements are largely independent.
Performance
AYTU vs. LYSDY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AYTU achieves a -13.46% return, which is significantly lower than LYSDY's 55.50% return.
AYTU
- 1D
- 0.00%
- 1M
- 2.74%
- YTD
- -13.46%
- 6M
- -11.42%
- 1Y
- 13.64%
- 3Y*
- 10.45%
- 5Y*
- -54.03%
- 10Y*
- —
LYSDY
- 1D
- -3.02%
- 1M
- -4.17%
- YTD
- 55.50%
- 6M
- 52.37%
- 1Y
- 118.34%
- 3Y*
- 39.33%
- 5Y*
- 25.47%
- 10Y*
- 74.37%
AYTU vs. LYSDY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AYTU Aytu BioPharma, Inc. | -13.46% | 52.94% | -40.14% | -24.87% | -86.00% | -77.42% | -38.35% | 22.41% | -98.22% | -89.38% |
LYSDY Lynas Rare Earths Ltd ADR | 55.50% | 109.37% | -18.22% | -8.17% | -29.21% | 144.41% | 79.88% | 50.87% | 489.58% | 146.75% |
Correlation
The correlation between AYTU and LYSDY is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Feb 1, 2017 | 0.08 |
Fundamentals
AYTU:
$23.65M
LYSDY:
$12.64B
AYTU:
-$2.91
LYSDY:
A$0.14
AYTU:
0.47
LYSDY:
14.85
AYTU:
0.67
LYSDY:
5.38
AYTU:
$56.60M
LYSDY:
A$1.19B
AYTU:
$36.14M
LYSDY:
A$301.27M
AYTU:
-$27.34M
LYSDY:
A$236.57M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AYTU vs. LYSDY — Risk / Return Rank
AYTU
LYSDY
AYTU vs. LYSDY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aytu BioPharma, Inc. (AYTU) and Lynas Rare Earths Ltd ADR (LYSDY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AYTU | LYSDY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.59 | ||
| Sortino ratioReturn per unit of downside risk | -1.55 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 1.29 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | 0.39 | 2.57 | -2.18 |
| Martin ratioReturn relative to average drawdown | 0.88 | 5.31 | -4.43 |
Loading charts...
Drawdowns
AYTU vs. LYSDY - Drawdown Comparison
The maximum AYTU drawdown since its inception was -100.00%, roughly equal to the maximum LYSDY drawdown of -99.93%. Use the drawdown chart below to compare losses from any high point for AYTU and LYSDY.
Loading charts...
Drawdown Indicators
| AYTU | LYSDY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -99.93% | -0.07% |
Max Drawdown (1Y)Largest decline over 1 year | -35.47% | -46.39% | +10.92% |
Max Drawdown (3Y)Largest decline over 3 years | -70.24% | -46.39% | -23.85% |
Max Drawdown (5Y)Largest decline over 5 years | -99.04% | -58.25% | -40.79% |
Max Drawdown (10Y)Largest decline over 10 years | — | -72.35% | — |
Current DrawdownCurrent decline from peak | -100.00% | -53.49% | -46.51% |
Average DrawdownAverage peak-to-trough decline | -95.27% | -84.44% | -10.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.61% | 22.38% | -6.77% |
Volatility
AYTU vs. LYSDY - Volatility Comparison
Aytu BioPharma, Inc. (AYTU) has a higher volatility of 16.08% compared to Lynas Rare Earths Ltd ADR (LYSDY) at 13.99%. This indicates that AYTU's price experiences larger fluctuations and is considered to be riskier than LYSDY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AYTU | LYSDY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.08% | 13.99% | +2.09% |
Volatility (6M)Calculated over the trailing 6-month period | 34.49% | 44.04% | -9.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 55.68% | 65.04% | -9.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 85.38% | 50.74% | +34.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 187.81% | 278.66% | -90.85% |
Dividends
AYTU vs. LYSDY - Dividend Comparison
Neither AYTU nor LYSDY has paid dividends to shareholders.
Financials
AYTU vs. LYSDY - Financials Comparison
This section allows you to compare key financial metrics between Aytu BioPharma, Inc. and Lynas Rare Earths Ltd ADR. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AYTU vs. LYSDY - Profitability Comparison
AYTU - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aytu BioPharma, Inc. reported a gross profit of 7.60M and revenue of 12.41M. Therefore, the gross margin over that period was 61.2%.
LYSDY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Lynas Rare Earths Ltd ADR reported a gross profit of 114.53M and revenue of 406.10M. Therefore, the gross margin over that period was 28.2%.
AYTU - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aytu BioPharma, Inc. reported an operating income of -4.06M and revenue of 12.41M, resulting in an operating margin of -32.8%.
LYSDY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Lynas Rare Earths Ltd ADR reported an operating income of 79.26M and revenue of 406.10M, resulting in an operating margin of 19.5%.
AYTU - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aytu BioPharma, Inc. reported a net income of -5.62M and revenue of 12.41M, resulting in a net margin of -45.3%.
LYSDY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Lynas Rare Earths Ltd ADR reported a net income of 78.74M and revenue of 406.10M, resulting in a net margin of 19.4%.
Frequently Asked Questions
AYTU and LYSDY have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AYTU has higher volatility (16.08%) compared to LYSDY (13.99%). In terms of maximum drawdown, AYTU dropped -100.00% vs LYSDY's -99.93%.
LYSDY currently has the higher Sharpe Ratio (1.83 vs 0.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AYTU and LYSDY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer